How FucoVital™ may contribute to improved triglycerides levels and positively affect metabolic syndrome
fucoxanthin was shown in a pre clinical study to inhibit lipase activity in the gastrointestinal tract resulting in decreased triglyceride absorption
Algatech Triples FucoVital Production Capacity
Algatech announces it has tripled its production capacity for FucoVital. The action follows increased demand from the dietary supplements market.
Nonalcoholic Fatty Liver and How Fucoxanthin Might Help
FucoVitalTM is the only 3% fucoxanthin extract that targets the first stage of fatty liver by reducing the simple accumulation of fat in the liver. Algatech’s FucoVitalTM is, the first fucoxanthin derived from microalgae and is cultivated year-round in an industrial closed and controlled system, fully exposed to natural sunlight
Study shows FucoVital to be more effective than Silymarin in preventing harmful fat accumulation in liver cells
FucoVital shown to be more effective than Silymarin in preventing harmful fat accumulation in liver cells